Investing
The Indian rupee opened at an all-time low on December 3, slipping past the 90-per-dollar threshold as persistent foreign portfolio investor (FPI) outflows and...
Hi, what are you looking for?
The post A tale of two bids: What Netflix and Paramount’s pursuit of WBD means for Hollywood, viewers and investors appeared first on Invezz
The post Novo Nordisk brings Ozempic to India as weight-loss demand accelerates appeared first on Invezz
JPMorgan Chase is preparing another expansion step in India, setting the stage for a fresh phase of growth in a country that has become...
Like its sister metal gold, silver has been attracting renewed attention as a safe-haven asset. Although silver continues to exhibit its hallmark volatility, a...
Copper prices were volatile in 2025 due to supply-side constraints, high demand and geopolitical concerns. Experts are calling for many of these trends to...
The Indian rupee opened at an all-time low on December 3, slipping past the 90-per-dollar threshold as persistent foreign portfolio investor (FPI) outflows and...
The post Apple privacy concerns rise as India orders mandatory installation of cyber safety app appeared first on Invezz
The post South Korea cyber crisis deepens as Coupang data leak exposes national vulnerabilities appeared first on Invezz
The post Winners vs. losers in a bruised November: can the S&P 500 recover in December? appeared first on Invezz
The post Why is CoinShares axing its XRP, Solana and Litecoin ETFs just days before its US debut? appeared first on Invezz
The post Baidu launches major layoffs as ad revenue falls and AI competition intensifies: report appeared first on Invezz
Puma shares rallied more than 13% on Thursday after reports that Chinese sportswear giant Anta Sports is weighing a potential bid for the German...
Italy’s antitrust regulator has widened its investigation into Meta Platforms after identifying new concerns linked to the company’s artificial intelligence tools on WhatsApp.The latest...
SoftBank Group shares tumbled to a 2½-month low on Tuesday, extending a sharp two-day selloff triggered by concerns that Alphabet’s latest Gemini artificial intelligence...
Bayer shares surged on Monday after the company reported encouraging late-stage clinical trial results for its experimental cardiovascular drug asundexian, offering a rare boost...